1. Home
  2. NERV vs AIRI Comparison

NERV vs AIRI Comparison

Compare NERV & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NERV
  • AIRI
  • Stock Information
  • Founded
  • NERV 2007
  • AIRI 1979
  • Country
  • NERV United States
  • AIRI United States
  • Employees
  • NERV N/A
  • AIRI N/A
  • Industry
  • NERV Biotechnology: Pharmaceutical Preparations
  • AIRI Military/Government/Technical
  • Sector
  • NERV Health Care
  • AIRI Industrials
  • Exchange
  • NERV Nasdaq
  • AIRI Nasdaq
  • Market Cap
  • NERV 12.6M
  • AIRI 13.4M
  • IPO Year
  • NERV 2014
  • AIRI N/A
  • Fundamental
  • Price
  • NERV $1.77
  • AIRI $3.38
  • Analyst Decision
  • NERV Hold
  • AIRI
  • Analyst Count
  • NERV 1
  • AIRI 0
  • Target Price
  • NERV $5.00
  • AIRI N/A
  • AVG Volume (30 Days)
  • NERV 12.2K
  • AIRI 38.5K
  • Earning Date
  • NERV 08-05-2025
  • AIRI 08-13-2025
  • Dividend Yield
  • NERV N/A
  • AIRI N/A
  • EPS Growth
  • NERV N/A
  • AIRI N/A
  • EPS
  • NERV 0.83
  • AIRI N/A
  • Revenue
  • NERV N/A
  • AIRI $53,182,000.00
  • Revenue This Year
  • NERV N/A
  • AIRI $5.59
  • Revenue Next Year
  • NERV N/A
  • AIRI $5.00
  • P/E Ratio
  • NERV $2.18
  • AIRI N/A
  • Revenue Growth
  • NERV N/A
  • AIRI 0.29
  • 52 Week Low
  • NERV $1.15
  • AIRI $3.00
  • 52 Week High
  • NERV $3.50
  • AIRI $9.44
  • Technical
  • Relative Strength Index (RSI)
  • NERV 57.10
  • AIRI 46.11
  • Support Level
  • NERV $1.62
  • AIRI $3.31
  • Resistance Level
  • NERV $1.83
  • AIRI $3.72
  • Average True Range (ATR)
  • NERV 0.09
  • AIRI 0.20
  • MACD
  • NERV -0.00
  • AIRI -0.01
  • Stochastic Oscillator
  • NERV 64.29
  • AIRI 14.63

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Share on Social Networks: